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Letter to the Editor 
 
Dear Editors, 
In May 2013, the American Psychiatric Association (APA) released the fifth edition of 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). DSM-5 features a 
chapter in Section III with ‘conditions for further study’ that were determined by the 
Task Force and Work Groups as currently providing “insufficient evidence to warrant 
inclusion as official mental disorder diagnoses in Section II” and that thus are not 
intended for clinical use. The first ‘condition for further study’ listed in this section is 
the ‘attenuated psychosis syndrome’ which has been the matter of extensive, 
controversial and long-standing debate among experts in the field of early psychosis 
(Corcoran et al., 2010 and Yung et al., 2010). Implementation of this syndrome into 
DSM-5 is an appraisal of the results yielded over almost two decades of research of 
patients with clinical psychosis risk states (Fusar-Poli et al., 2013), with the term 
‘attenuated psychosis syndrome’ finally being favored over the initially suggested 
‘psychosis risk syndrome’ due to concerns about stigma. 
The Section III, however, is not the only section that features the ‘attenuated 
psychosis syndrome’. Indeed, the very same diagnosis is explicitly mentioned in 
Section II among the examples for presentation of ‘Other Specified Schizophrenia 
Spectrum and Other Psychotic Disorder’ (298.8). Although in Section II the proposed 
criteria and diagnostic features are not presented at such length as in Section III, the 
main clinical feature, i.e. that “this syndrome is characterized by psychotic-like 
symptoms that are below a threshold for full psychosis”, is identically reproduced as 
in Section III. This is not the only intriguing ‘finding’ with regard to the new ‘attenuated 
psychosis syndrome’ in DSM-5. It is further noteworthy that its Section II DSM-5 code 
298.8 is the same as the one applied for DSM-5 ‘Brief Psychotic Disorders’, i.e. a 
disorder with symptom level that transgresses psychotic threshold and that in general 
requires antipsychotic medication and often psychiatric inpatient care. 
One of the main concerns of implementing an ‘attenuated psychosis syndrome’ in 
DSM-5 Section III and not in Section II emerged from more recent findings that a 
substantial proportion of individuals that meet formal at-risk criteria for psychosis 
actually do never develop psychosis and in some cases even fully remit (Simon and 
Umbricht, 2010 and Simon et al., 2011). Allocating these individuals prematurely to a 
DSM-5 Section II disorder would result in an unintentional scenario with unwarranted 
treatment regimens and imminent stigma (Yung et al., 2012). However, the 
concurrent inclusion of the very same ‘attenuated psychosis syndrome’ in Section II, 
even simply as quasi synonym for ‘Other Specified Schizophrenia Spectrum and 
Other Psychotic Disorder’, is disconcerting. It obscures above mentioned concerns 
and the explicit statement in DSM-5 that only criteria sets and disorders in Section II, 
but not proposed criteria sets in Section III are intended for clinical use. 
Subsequently, as DSM novices may lay their primary focus on the official mental 
disorders according to Section II, there is some justified concern that this scenario 
may transform the ‘attenuated psychosis syndrome’ into a disorder for which it initially 
was not intended when implemented in DSM-5, i.e. into a Section II diagnosis for 
clinical use instead of a Section III not intended for clinical use. We thus propose that 
the ‘attenuated psychosis syndrome’ be removed as synonym for ‘Other Specified 
Schizophrenia Spectrum and Other Psychotic Disorder’ and thus from Section II. 
With this short contribution, the present authors may be happy to enhance a reply by 
the ‘attenuated psychosis syndrome’ Work Group. 
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